NDATOPICALSPONGE
Approved
Oct 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 7h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRE-OP II is a topical antimicrobial sponge containing hexachlorophene, approved in 1978 for pre-operative skin antisepsis. It is indicated for use as a surgical scrub and skin antiseptic to reduce microbial flora on the skin prior to surgery. The agent works by disrupting bacterial cell membranes through halogenation.
LOE Approaching
This mature, hospital-based surgical antiseptic faces LOE pressure and likely operates with a small, maintenance-focused commercial team focused on hospital contracts rather than retail growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job postings and approaching LOE, PRE-OP II offers limited career growth prospects; roles are primarily maintenance-focused and concentrated in hospital sales and account management. Career movement likely involves lateral shifts to growth-stage products or external opportunities rather than vertical advancement within this brand.
Hospital Account Manager
Worked on PRE-OP II at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.